Announcements Trials
Browse Landscape

Phase

Phase 2 14Phase 3 4Phase 1 2Phase 4 1Phase 2/3 1Phase 1/2 1

Status

Unknown 3Recruiting 1

Sponsor Class

OTHER 4INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Stomach Neoplasms 4

Interventions

Cisplatin 294Radiotherapy 230Fluorouracil 201Cyclophosphamide 191Capecitabine 183Docetaxel 167Gemcitabine 165Oxaliplatin 162Carboplatin 161Paclitaxel 152Leucovorin 122Drug Therapy 119Dexamethasone 119Doxorubicin 112Etoposide 99Bevacizumab 91Cytarabine 87Vincristine 83Irinotecan 81Rituximab 77Epirubicin 71Prednisone 65Radiosurgery 63Methotrexate 62Surgical Procedures, Operative 61Radiation 60Radiotherapy, Intensity-Modulated 57Neoadjuvant Therapy 53Lenalidomide 52Letrozole 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × OTHER × gimeracil × Clear all
NCT03941561 2019-05-31

S-1 for 9 Months Versus 1 Year for Stage II Gastric Cancer (SMAC)

Fudan University

Phase 3 Recruiting
1,006 enrolled
Gastrointestinal

Stomach Neoplasms

NCT03475615 2018-03-23

A Study of Intraperitoneal Paclitaxel in Combination With SOX Compared With SOX Alone in Gastric Cancer With Malignant Ascites

Fudan University

Phase 3 Unknown
215 enrolled
Gastrointestinal

Stomach Neoplasms

NCT02008422 2013-12-11

Clinical Study of Endostar Injection Concomitant With SOX Protocols to Treat Advanced Gastric Cancer

Xinjiang Medical University

Phase 3 Unknown
120 enrolled
Gastrointestinal

Stomach Neoplasms

NCT01198392 2011-07-25

Trial of S-1 Plus Cisplatin in Gastric Cancer

Sun Yat-sen University

Phase 3 Unknown
270 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡